Robert Chen and his team like strategies like direct indexing because they systematically tax loss harvest throughout the ...
Morgan Stanley has upgraded Gilead Sciences (NASDAQ:GILD) to overweight from equal weight, citing the company's HIV drug ...
Morgan Stanley closed $12.79 short of its 52-week high ($136.24), which the company achieved on November 25th.
While Citi, BofA and Goldman touted their biggest cohorts of managing directors in years, Morgan Stanley elevated greater ...
"Everybody knows you made a mistake. How are you going to deal with that?" ...
Morgan Stanley upgraded Vir Biotechnology (NASDAQ:VIR) to Overweight from Equal Weight on Thursday after the cancer drug ...
Vir Biotechnology's Phase 1 data highlights early promise for T-cell engagers targeting HER2-positive tumors and prostate ...
The popularity of alcohol-free Guinness won’t protect the shares of its owner Diageo Plc from the growing trend toward health ...
Morgan Stanley Mortgage Capital Holdings has scheduled a foreclosure auction for the 2.2M SF office park near the ...
Mike Wilson, Morgan Stanley's chief investment officer, has some advice for anyone looking to advance in their career: Take ...